GSK, Pfizer deal goes to in-depth Phase 2 review in the Philippines
MLex Summary: GlaxoSmithKline's proposed takeover of Pfizer's global consumer healthcare business will undergo a more in-depth Phase 2 review from the Philippine Competition Commission. The commission's initial 30-day preliminary review that...To view the full article, register now.
Already a subscriber? Click here to view full article